Effect of immunomodulatory therapies on mortality in adults hospitalised with COVID-19 and non-COVID-19 community-acquired pneumonia: A systematic review and meta-analysis
Effect of immunomodulatory therapies on mortality in adults hospitalised with COVID-19 and non-COVID-19 community-acquired pneumonia: A systematic review and meta-analysis. // Clinical Microbiology and Infection. – URL: https://www.sciencedirect.com/science/article/pii/S1198743X26006166?dgcid=rss_sd_all
Effect of immunomodulatory therapies on mortality in adults hospitalised with COVID-19 and non-COVID-19 community-acquired pneumonia: A systematic review and meta-analysis. Clinical Microbiology and Infection. https://www.sciencedirect.com/science/article/pii/S1198743X26006166?dgcid=rss_sd_all
“Effect of immunomodulatory therapies on mortality in adults hospitalised with COVID-19 and non-COVID-19 community-acquired pneumonia: A systematic review and meta-analysis.” Clinical Microbiology and Infection.
@article{article41000,
title = {Effect of immunomodulatory therapies on mortality in adults hospitalised with COVID-19 and non-COVID-19 community-acquired pneumonia: A systematic review and meta-analysis},
journal = {Clinical Microbiology and Infection},
url = {https://www.sciencedirect.com/science/article/pii/S1198743X26006166?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...